Molecular remission rates
Time from CR, mo . | No. patients PCR negative at or beyond date in question and positive before date in question . | Molecular remissions, no. (%, 95% CI) . |
|---|---|---|
| 3 | 29 | 29 (100, 88-100) |
| 6 | 33 | 33 (100, 89-100) |
| 12 | 23 | 20 (87,* 66-97) |
| 24 | 12 | 9 (75,† 43-95) |
| Longer than 24 | 11 | 8 (73,‡ 39-94) |
Time from CR, mo . | No. patients PCR negative at or beyond date in question and positive before date in question . | Molecular remissions, no. (%, 95% CI) . |
|---|---|---|
| 3 | 29 | 29 (100, 88-100) |
| 6 | 33 | 33 (100, 89-100) |
| 12 | 23 | 20 (87,* 66-97) |
| 24 | 12 | 9 (75,† 43-95) |
| Longer than 24 | 11 | 8 (73,‡ 39-94) |
Twenty patients were PCR negative at 12 months or later. But there were 3 patients who were PCR positive at 9 months. Counting these 3, there were 23 “evaluable” patients at 12 months, 20 of whom were PCR negative.
Nine patients were PCR negative at 24 months or later. But there were 3 patients who were PCR positive at 9 months. Counting these 3, there were 12 “evaluable” patients at 24 months, 9 of whom were PCR negative.
Eight patients were PCR negative at, respectively, 27, 28, 28, 28, 33, 33, 35, and 37 months from CR date. Counting the 3 patients who were PCR positive at 9 months, there were 11 patients who were evaluable at longer than 24 months, 8 of whom were PCR negative.